My Legacy Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$729K Buy
922
+364
+65% +$283K 0.26% 107
2025
Q1
$461K Buy
558
+102
+22% +$84.9K 0.18% 143
2024
Q4
$341K Buy
456
+225
+97% +$186K 0.13% 161
2024
Q3
$205K Sell
231
-20
-8% -$18K 0.08% 195
2024
Q2
$227K Buy
+251
New +$201K 0.07% 200

Other funds holding LLY

My Legacy Advisors's LLY Position: Q2 2025 in Review

My Legacy Advisors increased its Eli Lilly (LLY) stake by 65% in Q2 2025, buying an estimated $283K and bringing the position to 922 shares worth $729K. The position accounts for 0.26% of the portfolio, ranked #107.

My Legacy Advisors first reported a position in LLY in Q2 2024 and has held it in 5 quarters since. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • My Legacy Advisors held 922 shares of Eli Lilly worth $729K as of Q2 2025.
  • My Legacy Advisors bought 364 Eli Lilly shares in Q2 2025, an estimated $283K.
  • Eli Lilly made up 0.26% of My Legacy Advisors's portfolio in Q2 2025, its #107 holding.
  • My Legacy Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 5 quarters since.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on My Legacy Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.